Candida species are frequently found as saprophytes that colonize the surfaces of certain mucous membranes in human. The superficial and disseminated infections caused by them are largely opportunistic, and Candida albicans accounts for most of the etiologic species isolated from cutaneous candidiasis. Microscopic demonstration of yeast elements in potassium hydroxide preparations of infected tissue and cultural isolation of yeast from skin scrapings are used to confirm clinical diagnosis of cutaneous candidiasis. Rapid and highly sensitive diagnostic assays, based on PCR of DNA, have also been used to identify candidal pathogens in tissue (3, 4, 5, 7, 8) .
Candida species are frequently found as saprophytes that colonize the surfaces of certain mucous membranes in human. The superficial and disseminated infections caused by them are largely opportunistic, and Candida albicans accounts for most of the etiologic species isolated from cutaneous candidiasis. Microscopic demonstration of yeast elements in potassium hydroxide preparations of infected tissue and cultural isolation of yeast from skin scrapings are used to confirm clinical diagnosis of cutaneous candidiasis. Rapid and highly sensitive diagnostic assays, based on PCR of DNA, have also been used to identify candidal pathogens in tissue (3, 4, 5, 7, 8) .
The amplification of a targeted DNA sequence by PCR does not, however, indicate the viability of the source organism, important information for evaluating the efficacy of a particular therapy and thus for avoiding an unnecessary prolongation of therapy. For this reason, reverse transcription (RT)-PCR of mRNA molecules has been used to assess the viability of microorganisms (9, 11, 14) . However, RT-PCR is a qualitative assay, and this places a limitation on the inferences that can be drawn from the result; differences in the quantities of target mRNAs cannot easily be ascertained from the intensities of amplification bands. A determination of quantitative differences is needed in an assessment of the potencies of different concentrations of an agent or the progressive efficacy of a particular treatment. Furthermore, with the template at low levels, bands are seldom visualized in gel, resulting in falsenegative interpretations (14) .
In this study, we estimated the viability of C. albicans in a reconstituted-skin model of cutaneous candidiasis by detection of C. albicans ACT mRNA using the LightCycler (LC) system (a two-step RT-PCR-fluorescent hybridization [FH] assay) (10) . LC DNA-based identification of fungi has been shown to be highly sensitive and rapid (10) , and we applied of this system to rapidly quantify C. albicans ACT mRNA. The ACT mRNA was specifically targeted because of the constitutive nature of the gene and the major role of actin in cell division (6, 15) .
MATERIALS AND METHODS
Materials. An isolate of C. albicans (serotype A; JUH 3181) was used. The isolate was obtained from the Juntendo University Hospital culture collection. Amorolfine powder was a gift from Kyorin Pharmaceutical Co. Ltd. (Tokyo, Japan).
Isolation of fungal total RNA. A single C. albicans colony from a 24-h Sabouraud dextrose agar culture was inoculated into 5 ml of Sabouraud broth. The culture was incubated at 30°C with orbital shaking for 18 h. The yeast cells were harvested by centrifugation at 3,000 ϫ g and 4°C for 5 min and washed three times in phosphate-buffered saline (PBS). The cells were homogenized by grinding them with a pellet mixer and then by passaging them several times through a 23-guage needle. Total RNA was extracted by the guanidine isothiocyanatephenol method (2) using Isogen (Wako Junyaku Kogyo, Osaka, Japan) according to the manufacturer's instructions.
Design of PCR primers and fluorescent hybridization (FH) probes. Figure 1 shows a schematic representation of the C. albicans ACT gene indicating the target areas of the primers and probes. The primers and probes were based on the published sequence of the actin genes of C. albicans (GenBank accession no. X16377). The uniqueness of the primers and probes for C. albicans ACT1 was determined using the BLAST database search program (1), courtesy of The Institute for Genomic Research (http://www.tigr.org.).
The PCR primers were 5Ј-ACGGTGAAGAAGTTGCTGCT-3Ј (CF; bp 5 to 23) and 5Ј-GGGCTTCATCACCAACATAAG Ϫ3Ј (CR; bp 158 to 178). The upstream primer spanned the exon-exon boundaries of ACT, thus excluding the amplification of genomic DNA. The FH probes, 5Ј-TAGACCAAGACATCAA GGTATCATGG-3Ј (H1; bp 87 to 109) and 5Ј-AGCTGTTTTCCCATCTCTTG TTG-3Ј(H2; bp 111 to 136), were respectively labeled at the 5Ј and 3Ј ends with LC Red 640 fluorophore and fluorescein (Roche Diagnostics GmbH, Mannheim, Germany). The former was also modified at the 3Ј end by phosphorylation to avoid extension during PCR. The probes anneal to adjacent internal sequences of the ACT, 1 bp apart, thus enabling fluorescent resonance energy transfer between the fluorophores (10) .
Preparation of the pACT plasmid, a standard ACT mRNA quantification reference. A 192-bp C. albicans ACT exon fragment containing the target ACT fragment was amplified by RT-PCR (RNA PCR kit; TaKaRa Shuzo Co. Ltd., Ohtsu, Japan) using 5Ј-ATGGACGGTGAAGAAGTTGC-3Ј (SF; bp 1 to 20) and 5Ј-ACCTCTTTTGGATTGGGCTTCA-3Ј (SR; bp 171 to 192) (Fig. 1) . RT was performed with a 20-l reaction mixture containing 1ϫ RNA PCR buffer (10 mM Tris-HCl, pH 8.3); 50 mM KCl; 250 M (each) dTTP, dUTP, dATP, and dGTP; 2.5 U of avian myeloblastosis virus reverse transcriptase, 5 mM MgCl 2 , 20 U of an RNase inhibitor, and a 0.125 M concentration of the oligo(dT) adapter nucleotide primer. RT was performed in a DNA thermal cycler (model 480; Perkin-Elmer, Norwalk, Conn.) with one cycle of 30°C for 10 min, 50°C for 30 min, 99°C for 5 min, and 4°C for 5 min.
PCR was performed in the same tube, with the final 100-l reaction mixture containing 1ϫ RNA PCR buffer, 2.5 mM MgCl 2 , 2.5 U of Taq polymerase, and a 20 pM concentration of each of the primers SF and SR. PCR was performed in a DNA thermal cycler with 1 cycle of 5 min at 95°C; 30 cycles of 1 min at 95°C, 30 s at 62°C, and 30 s at 72°C; and a final extension at 72°C for 5 min. Amplification products were separated by electrophoresis through 1.5% (wt/vol) agarose gel containing 0.5 g of ethidium bromide/ml. The band of the amplification product of the expected size was cut from the gel and purified using a MERmaid kit (Bio 101 Inc., Vista, Calif.) as instructed by the manufacturer. The amplicon was sequenced using the PCR primers and a dRhodamine terminator cycle sequencing kit (Perkin-Elmer) according to the manufacturer's instructions. Sequence analysis was performed on an ABI PRISM 310 genetic analyzer (PerkinElmer).
The 192-bp ACT exon fragment was ligated into the pCR 2.1 plasmid vector (3.9 kb) and transformed into One Shot cells (INV␣FЈ) using a TA cloning kit (Invitrogen Corp., Carlsbad, Calif.) as instructed by the manufacturer. Dilutions of the plasmid containing the cloned insert (pACT; 4.092 kb) were then used as the standard reference templates for detection and quantification of ACT mRNA by the LC RT-PCR-FH assay.
Sensitivity of the LC RT-PCR-FH system. The template, pACT, was diluted to contain 20 ng, 200 pg, 2 pg, 20 fg, 2 fg, or 1 fg of DNA/l. The LC RT-PCR-FH assay was performed with a 20-l reaction mixture in glass capillaries which contained 2 l of the template, 4 mM MgCl 2 , a 0.5 M concentration of each of the PCR primers CF and CR, a 0.2 M concentration of each of the FH probes H1 and H2, and 1ϫ LC DNA master hybridization mixture (ready-to-use reaction mix containing DNA polymerase). The cycle program data of LightCycler software (version 3; Roche Diagnostics GmbH) were set at 1 cycle of denaturation at 95°C for 2 min; 60 cycles of 95°C for 0 s (once this temperature is reached, it immediately falls to the annealing temperature), annealing at 62°C for 10 s, and extension at 72°C for 7 s; and 1 cycle of cooling at 40°C for 30 s. Other program data were set as instructed by the manufacturers. PCR amplification dynamics were monitored online.
The LC RT-PCR-FH product was recovered from the capillary tubes and separated by electrophoresis on a 1.5% (wt/vol) agarose gel.
Specificities of the PCR primers and FH probes in the LC system. The total RNA extracts of C. albicans (ATCC 76615) . Total RNA extract of human keratinocytes was also used as a template. RT was performed, and the product was assayed by the LC RT-PCR-FH method as described above.
Infection of a reconstituted human skin model with C. albicans. The reconstituted skin (Testskin; Toyobo Co. Ltd., Tokyo, Japan) consisted of human dermal fibroblasts in a collagen lattice overlaid by stratified human keratinocytes. Six wells of the model were set up as instructed by the manufacturer. The inoculum, C. albicans, was cultured in Sabouraud broth and adjusted to a density of 2 ϫ 10 3 cells per ml of PBS. Fifty microliters of the C. albicans suspension was inoculated onto the skin surface in each of five wells. Fifty microliters of PBS was applied to the sixth skin model as a negative infection control. The skin model was maintained in serum-free Testskin assay medium (Toyobo Co. Ltd.) at 37°C for 48 h in an atmosphere of 5% CO 2 -95% O 2 .
Five, 10, 20, or 40 g of amorolfine, in a 50-l PBS solution, was applied to the surfaces of four C. albicans-infected skin models at 48 and 96 h postinfection, and the tissue maintenance medium was replaced with a fresh medium containing 5 g of amorolfine/ml. Fifty microliters of PBS was also applied to the positiveand negative-infection control skin models, and the tissue maintenance medium was drug free in both cases. At 6 days postinfection, a 6-mm-diameter portion of skin was excised with a punch and the total RNA content was extracted. The remaining portion was inoculated on Sabouraud agar.
Extraction of total RNA from the skin model and quantification of C. albicans ACT mRNA. The skin fragment was weighed, minced, and suspended in 500 l of 10 mM Tris-HCl buffer (pH 7.8) containing 1 mM CaCl 2 O⅐2H 2 O, 10 mM dithiothreitol, 20 U of an RNase inhibitor, and 500 g of proteinase K. The mixture was incubated at 37°C for 45 min and then centrifuged for 3 min at 3,000 ϫ g and 4°C. The precipitate was washed once in 1 ml of chelating buffer containing 10 mM Tris-HCl (pH 7.8) and 2 mM EGTA and then suspended in 1 ml of Isogen (Wako Junyako Kogyo Ltd.). Total RNA was extracted as described earlier.
RT was performed as described above, and a negative control, which contained water in place of reverse transcriptase, was included for each sample. The RT product and 10 6 , 10 5 , and 10 4 copies of pACT/l were then used as templates in the LC RT-PCR-FH. Postamplification analysis was carried out with LC data analysis software (version 3.1.102; Roche Diagnostics GmbH), and the copy number of the template was determined. The concentration of C. albicans ACT mRNA, in copy number per milligram of skin, was then calculated using the following formula: (copy number of the ACT cDNA template in the test reaction mixture Ϫ background quantity in the control reaction mixture) ϫ dilution factor of RT reaction mixture ϫ volume of total RNA extract/mass of skin fragment (in milligrams).
The LC RT-PCR-FH products were recovered from the capillary tubes, electrophoresed on a 1.5% (wt/vol) agarose gel, and purified. Both strands of the purified product were sequenced as described above using the PCR primers.
RESULTS

Sensitivity of the LC RT-PCR-FH system.
Amplification of different concentrations of pACT was monitored online by regular-log-fluorescence versus cycle number curves (Fig. 2) . The irregular curve below the noise band cursor indicated nonamplification of the negative control (water). The system could detect 1 fg of pACT, and this number was equivalent to 2.2 copies of pACT. The calculation of the copy number was as described elsewhere (15) the stated copy number. Figure 3 shows the results of agarose gel electrophoresis of the amplification products from the pACT concentrations.
Specificity. The ACT-based PCR primers and FH probes were specific for C. albicans as indicated by regular-log-fluorescence versus cycle number curves (not shown). The negative control, reference organisms, and human templates were not amplified, as is indicated by irregular curves below the noise band cursor. Electrophoresis of the LC RT-PCR-FH products showed a single band for the amplification product of the expected size of 174 bp from C. albicans; no band was observed in the reaction product of the reference organisms and human keratinocytes (Fig. 4) .
Viability assessment of C. albicans in skin samples by quantification of the ACT mRNA. Table 1 shows a summary of quantification of C. albicans ACT mRNA in the infected-skin model by the two-step LC RT-PCR-FH system. The copy numbers of C. albicans ACT mRNA per milligram of tissue decreased with an increase in the amount of drug applied. The untreated control expectedly yielded the highest copies of ACT mRNA per milligram of skin. An amorolfine control, using water containing 10 or 100 g of drug/ml in the RT assay mixture, showed that amorolfine had no effect on the calculated amount of ACT mRNA per milligram of skin of the untreated control (data not shown). No fluorescent signal was generated by the uninfected control. With the exception of what occurred with the skin model to which was applied 20 g of amorolfine, the presence of C. albicans ACT in the skin model corresponded with isolation of the organism in Sabouraud dextrose agar cultures of tissue samples. Electrophoretic analysis of the LC RT-PCR-FH product from the ACT mRNA-positive samples showed an amplicon of the expected size of 174 bp in agarose gel. A nucleotide sequence analysis of the product showed complete identity with the targeted fragment of the C. albicans ACT exon.
DISCUSSION
Routine qualitative RT-PCR assay has been used in assessing the viability of microorganisms by targeting the heat shock protein 70 mRNAs of Pneumocystis carinii (11) , Giardia cysts, and Cryptosporidium oocysts (9) and the actin mRNA of C. albicans (14) . In this study, we quantified C. albicans actin mRNA as a means of assessing the viability of C. albicans in a reconstituted-human-skin model of cutaneous candidiasis following the application of the antimycotic. Amorolfine was used because of its effectiveness in the topical therapy of superficial mycoses caused by yeasts and dermatophytes and its high affinity to stratum corneum and nails (12, 13) .
The two-step LC RT-PCR-FH system was used to detect and quantify mRNA. The system combines rapid PCR-FH in glass capillaries with online fluorescence detection of the hybridized PCR amplicon (10) . We further developed a method The LC system proved itself extremely sensitive in detecting 1 fg of the standard plasmid online, with a reproducibility of 100% among five replicates. In contrast, the LC PCR products of 2 or 1 fg of pACT did not show any visible band on an electrophoretic gel (Fig. 3) . This result showed that detection of amplicons by means of FH in the LC system was more sensitive than visual observation of amplicon bands in gels. Thus, the LC system has sufficient sensitivity to detect ACT mRNA expressed from a single genome of C. albicans comparable to that reported for the 5Ј nuclease TaqMan PCR assay (16) . Although the extreme sensitivity of the system may not be a priority in cutaneous candidiasis, our model has conveniently demonstrated that this system is applicable to other mycoses provided that the appropriate primers and hybridization probes are used.
The PCR primers and FH probes, based on the ACT exon, were specific for C. albicans. Although the ACT sequence is highly conserved among eukaryotes and much more so among Candida species (17) , the combination of PCR and hybridization at a high annealing temperature enhanced the specificities of the reagents in the LC system.
The quantity of ACT mRNA is related to the residual population of metabolically active yeasts, as evidenced by a decrease in signal per milligram of skin as the amount of the antimycotic agent applied to the infected skin model increased. However, the population of C. albicans in tissue cannot not be directly estimated from the number of copies of ACT mRNA since the quantity of mRNA in a cell, unlike that of the DNA, is varied and depends on the cellular metabolic state. The absence of C. albicans colonies in Sabouraud dextrose agar cultures of the ACT mRNA-positive skin model, which was treated with 20 g of amorolfine, may be due to the inhibitory effect of residual drug in tissue.
In conclusion, quantification of ACT mRNA by the LC system represents a sensitive, specific, rapid, and quantitative means of assessing the viability of fungi in an infected tissue. The fact that the average assay time from sample preparation through postamplification analysis was less than 4 h, compared to 24 to 48 h for traditional Candida culture results, underscores the ACT-LC combination potential for rapid evaluation of the viability of fungi in tissue and assessment of the therapeutic efficacies of antifungal drugs in the treatment of fungal diseases.
